The FDA lists BPC-157 among bulk drug substances that may present significant safety risks in compounding, citing concerns such as immune reactions, peptide-related impurities, and limited safety information
Research goals: Metabolic & Weight Description AOD-9604 (CAS 221231-10-3) is a synthetic 16-amino-acid peptide corresponding to the C-terminal fragment of human growth hormone (hGH 177191) with an additional N-terminal tyrosine added to enhance stability
By purchasing from our website, customers confirm that they are qualified researchers, laboratories, or research institutions and fully understand the research-use-only designation associated with these products
If any changes have occurred in your health since your consultation, let us know
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats